Cargando…
Evaluation of Nestin and EGFR in Patients with Glioblastoma Multiforme in a Public Hospital in Iran
INTRODUCTION: Glioblastoma multiforme (GBM) is a grade IV glioma and accounts for 15% of all primary brain tumors. This GBM has a median survival range of less than 2 years after diagnosis and it is highly vascularized by neoformed vessels. Neoangiogenesis is a crucial factor in the malignant tumora...
Autores principales: | Matini, Amir Hassan, Mofidi Naeini, Mohadeseh, Haddad Kashani, Hamed, Vakili, Zarichehr |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
West Asia Organization for Cancer Prevention
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7798165/ https://www.ncbi.nlm.nih.gov/pubmed/33112545 http://dx.doi.org/10.31557/APJCP.2020.21.10.2889 |
Ejemplares similares
-
Nestin expression in the cell lines derived from glioblastoma multiforme
por: Veselska, Renata, et al.
Publicado: (2006) -
Lycorine inhibits glioblastoma multiforme growth through EGFR suppression
por: Shen, Jia, et al.
Publicado: (2018) -
Circular RNAs and glioblastoma multiforme: focus on molecular mechanisms
por: Salami, Raziyeh, et al.
Publicado: (2022) -
Glioblastoma Multiforme
por: Sheehan, Jonas M., et al.
Publicado: (2012) -
Glioblastoma multiforme – an overview
por: Urbańska, Kaja, et al.
Publicado: (2014)